View Post

The Impact of Socioeconomic Status on HPV Infection Among Young Brazilians in a Nationwide Multicenter Study. Preventive Medicine Reports, 21: 1-7.

In by AHFJanuary 15, 2021

View Post

Incident Type 2 Diabetes Mellitus after Initiation of Common HIV Antiretroviral Drugs. AIDS, 35: 81-90.

In by AHFJanuary 15, 2021

View Post

Community Pharmacists: On the Frontline of Health Service Against COVID- 19 in LMICs. Research in Social and Administrative Pharmacy, 17: 1964-1966.

In by AHFJanuary 15, 2021

View Post

Brazilian Protocol for Sexually Transmitted Infections 2020: Acquired Syphilis. Journal of the Brazilian Society of Tropical Medicine, 54: 1-8.

In by AHFJanuary 15, 2021

View Post

Prevalence of human immunodeficiency virus-1 drugresistant mutations among adults on first- and second-line antiretroviral therapy in a resourcelimited health facility in Busia County, Kenya. The Pan African Medical Journal, 37(311): 1-11.

In by AHFDecember 15, 2020

View Post

Discrepancies Between Self-Reported Adherence and a Biomarker of Adherence in Real-World Settings. Journal of Acquired Immune Deficiency Syndrome, 85(4): 454-457.

In by AHFDecember 1, 2020

View Post

Antiretroviral Therapy and Liver Disorders in the OPERA® Cohort. Therapeutic Advances in Drug Safety, 11: 1-12.

In by AHFNovember 15, 2020

View Post

Risk of Chronic Kidney Disease in People Living with HIV by Tenofovir Disoproxil Fumarate (TDF) Use and Baseline D:A:D Chronic Kidney Disease Risk Score. HIV Medicine, 22(5): 325-333.

In by AHFNovember 1, 2020

View Post

Assessing Bias Introduced in Estimated Glomerular Filtration Rate by the Inhibition of Creatinine Tubular Secretion from Common Antiretrovirals. Antiviral Therapy, 25(5): 287-292.

In by AHFOctober 15, 2020

View Post

Hepatitis B Infection in People Living with HIV Who Initiate Antiretroviral Therapy in Zimbabwe. Public Health Action, 10(3): 97-103.

In by AHFSeptember 15, 2020